{"id":"https://openalex.org/A5031825744","orcid":"https://orcid.org/0009-0007-0531-8877","observed_orcids":["https://orcid.org/0009-0007-0531-8877"],"display_name":"Yogesh K. Chutake","raw_author_names":["Y. Chutake","Y. K. Chutake","Yogesh Chutake","Yogesh K Chutake","Yogesh K. Chutake"],"full_name":"Yogesh K. Chutake","works_count":53,"cited_by_count":548,"summary_stats":{"2yr_mean_citedness":1.3823529411764706,"h_index":11,"i10_index":12},"ids":{"openalex":"https://openalex.org/A5031825744","orcid":"https://orcid.org/0009-0007-0531-8877","observed_orcids":["https://orcid.org/0009-0007-0531-8877"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210124561","ror":"https://ror.org/02sjhcw37","display_name":"Accent Therapeutics (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124561"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4405273325","ror":"https://ror.org/05nj87k55","display_name":"Syros Pharmaceuticals (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4405273325"]},"years":[2022,2020]},{"institution":{"id":"https://openalex.org/I49332381","ror":"https://ror.org/0457zbj98","display_name":"University of Oklahoma Health Sciences Center","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]},"years":[2020,2018,2015,2011,2009,2007]},{"institution":{"id":"https://openalex.org/I8692664","ror":"https://ror.org/02aqsxs83","display_name":"University of Oklahoma","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]},"years":[2016,2015,2014]}],"last_known_institutions":[{"id":"https://openalex.org/I4210124561","ror":"https://ror.org/02sjhcw37","display_name":"Accent Therapeutics (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124561"]}],"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":39,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","count":36,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":23,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","count":10,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","count":6,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":0.0006554,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":0.0001843,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","value":0.0001401,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","value":0.000102,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","value":6.06e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","score":0.9214000105857849},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8885999917984009},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.8761844038963318},{"id":"502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","score":0.67330002784729},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.5201785564422607}],"counts_by_year":[{"year":2007,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2009,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2011,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":14},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2014,"works_count":2,"oa_works_count":2,"cited_by_count":19},{"year":2015,"works_count":2,"oa_works_count":2,"cited_by_count":23},{"year":2016,"works_count":1,"oa_works_count":1,"cited_by_count":17},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":24},{"year":2018,"works_count":1,"oa_works_count":0,"cited_by_count":25},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":28},{"year":2020,"works_count":4,"oa_works_count":1,"cited_by_count":37},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":32},{"year":2022,"works_count":3,"oa_works_count":1,"cited_by_count":49},{"year":2023,"works_count":3,"oa_works_count":1,"cited_by_count":44},{"year":2024,"works_count":5,"oa_works_count":1,"cited_by_count":65},{"year":2025,"works_count":13,"oa_works_count":13,"cited_by_count":68},{"year":2026,"works_count":16,"oa_works_count":15,"cited_by_count":66}],"display_name_alternatives":["Y. Chutake","Y. K. Chutake","Yogesh Chutake","Yogesh K Chutake","Yogesh K. Chutake"],"block_key":"y chutake","works_api_url":"https://api.openalex.org/works?filter=author.id:A5031825744","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5031825744","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}